MYX mayne pharma group limited

Improved Financial Performance for Mayne

  1. 1,060 Posts.
    lightbulb Created with Sketch. 86
    Delivered revenue growth in 2HFY23 across all segments to $131.5m (1HFY23: $52.1m). 2HFY23 gross profit increased
    to $66.6m (1HFY23: $16.9m) and positive direct contribution of $0.9m (1HFY23: negative direct contribution of $42.7m)
    ✓ Generated positive operating free cash flow of $14.1m in 2HFY23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.05
Change
0.040(0.80%)
Mkt cap ! $410.2M
Open High Low Value Volume
$5.02 $5.08 $4.97 $1.369M 273.1K

Buyers (Bids)

No. Vol. Price($)
1 1151 $5.01
 

Sellers (Offers)

Price($) Vol. No.
$5.09 5000 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.